This important report has been published by the Council for International Organizations of Medical Sciences (CIOMS) Working Group XI.
The report combines the experience and expertise of the CIOMS Working Group XI on Patient involvement in the development, regulation, and safe use of medicines as well as the views of members of the public, patient organization representatives, regulators, drug development experts, industry, academia, health professionals, and other related stakeholders.
It underlines the importance of systematically involving patients throughout a medicine’s life, from its early development through the regulatory process to ongoing monitoring and safe use in everyday healthcare. Moreover, the report provides a comprehensive overview of the current knowledge about the benefits of patient involvement and existing initiatives, presenting many examples and recommendations as well as addressing the remaining challenges and practice gaps.
The full report is available here.